BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 902163)

  • 1. A pharmacological study of SRS-A on the bovine cutaneous vasculature.
    Burka JF; Eyre P
    Can J Physiol Pharmacol; 1977 Aug; 55(4):904-8. PubMed ID: 902163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bovine SRS-A (SRS-Abov) on bovine respiratory tract and lung vasculature in vitro.
    Burka JF; Eyre P
    Eur J Pharmacol; 1977 Jul; 44(2):169-77. PubMed ID: 885166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of oxatomide on several activities of SRS-A and synthetic leukotrienes in guinea-pigs and rats.
    Ohmori K; Ishii H; Kubota T; Shuto K; Nakamizo N
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):139-50. PubMed ID: 2862849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antagonism of the mediators of allergy by a benzopyrano-benzopyran carboxylic acid PR-D-92-EA.
    Possanza GJ; Bauen A; Stewart PB
    Int Arch Allergy Appl Immunol; 1975; 49(6):789-95. PubMed ID: 336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow reacting substance of anaphylaxis (SRS-A) release from guinea-pig lung parenchyma during antigen- or ionophore-induced contraction.
    Fleisch JH; Haisch KD; Spaethe SM
    J Pharmacol Exp Ther; 1982 Apr; 221(1):146-51. PubMed ID: 6801255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of isolated airway responses to bronchoconstrictive agonists by the slow-reacting substance of anaphylaxis antagonist FPL 55712.
    Krell RD; Osborn R; Falcone K; Vickery L
    Prostaglandins; 1981 Sep; 22(3):423-32. PubMed ID: 6895417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contractile action of slow reacting substance of anaphylaxis (SRS-A) on rat isolated fundic strip and guinea-pig isolated ileum and its antagonism by FPL 55712.
    Feniuk L; Kennedy I; Whelan CJ
    J Pharm Pharmacol; 1982 Sep; 34(9):586-8. PubMed ID: 6127385
    [No Abstract]   [Full Text] [Related]  

  • 8. New antagonists of leukotrienes: ONO-RS-411 and ONO-RS-347.
    Obata T; Katsube N; Miyamoto T; Toda M; Okegawa T; Nakai H; Kosuge S; Konno M; Arai Y; Kawasaki A
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():229-31. PubMed ID: 2936099
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunopharmacological studies on mydocalm and related compounds as an antagonist of slow reacting substance of anaphylaxis (SRS-A).
    Nagai H; Matsuura N; Sato N; Koda A; Kohno S
    J Pharmacobiodyn; 1983 Nov; 6(11):874-80. PubMed ID: 6199492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of rotenone and related compounds as antagonists of slow-reacting substance of anaphylaxis.
    Ashack RJ; McCarty LP; Malek RS; Goodman FR; Peet NP
    J Med Chem; 1980 Sep; 23(9):1022-6. PubMed ID: 6106061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucotrienes, SRS-A and the vascular manifestations of PCA.
    Morley J; Page C; Paul W
    Agents Actions; 1981 Dec; 11(6-7):585-7. PubMed ID: 6122355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators].
    Ohmori K; Ishii H; Nito M; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):399-409. PubMed ID: 6138301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylaxis in guinea-pig peripheral airways in vitro.
    Mitchell HW; Denborough MA
    Eur J Pharmacol; 1979 Feb; 54(1-2):69-78. PubMed ID: 421743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of a partially purified preparation of slow-reacting substance of anaphylaxis on guinea pig tracheal spirals and parenchymal strips.
    Drazen JM; Lewis RA; Wasserman SI; Orange RP; Austen KF
    J Clin Invest; 1979 Jan; 63(1):1-5. PubMed ID: 762239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunological release of slow-reacting substance of anaphylaxis from bovine lung.
    Burka JF; Eyre P
    Can J Physiol Pharmacol; 1974 Dec; 52(6):1201-4. PubMed ID: 4451890
    [No Abstract]   [Full Text] [Related]  

  • 16. Production and antagonism of cutaneous vascular permeability in the guinea pig in response to histamine, leukotrienes and A23187.
    Rinkema LE; Bemis KG; Fleisch JH
    J Pharmacol Exp Ther; 1984 Sep; 230(3):550-7. PubMed ID: 6432999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species difference in increased vascular permeability by synthetic leukotriene C4 and D4.
    Ueno A; Tanaka K; Katori M; Hayashi M; Arai Y
    Prostaglandins; 1981 Apr; 21(4):637-48. PubMed ID: 6894798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine.
    Engineer DM; Niederhauser U; Piper PJ; Sirois P
    Br J Pharmacol; 1978 Jan; 62(1):61-6. PubMed ID: 74266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of tranilast on the release of slow reacting substance of anaphylaxis (SRS-A) and contraction of the smooth muscle].
    Komatsu H; Ujiie A; Naito J
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):47-55. PubMed ID: 6194082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activities of a chemically synthesized form of leukotriene E4.
    Welton AF; Crowley HJ; Miller DA; Yaremko B
    Prostaglandins; 1981 Feb; 21(2):287-96. PubMed ID: 6261299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.